/
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Leptomeningeal Metastases is an emerging landscape with 12 programs across 6 companies. The most active players are Princess Maxima Center for Pediatric Oncology, Plus Therapeutics. 2 programs are in Phase 3.
Intelligence
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Bubble size = clinical trials
Key Players
Pipeline
Analysis
91%
Small molecule
10 of 11 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 11 classified programs, each share of the total. Modality classified for 92% of 12 pipeline programs.
Analysis
19
clinical trials
Clinical Trials
19 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)